← back to search

Murali Chintagumpala

Institute of Molecular and Cell Biology · US
Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Brain Metastases and Treatment, and Ocular Oncology and Treatments.
h-index
71
citations
16,888
works
509
NIH funding
primary concept
Medicine
email

Recent publications

Clinical Correlates of Anxiety and Depression After Diagnosis of a Pediatric Brain Tumor.
2026cited by 0position: contributordoi
Pseudoprogression in Pediatric Spinal Pilocytic Astrocytoma and Myxopapillary Ependymoma after Proton Therapy: A Case Series.
2025cited by 0position: contributordoi
A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1).
2024cited by 5position: contributordoi
Late-onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma.
2024cited by 0position: contributordoi
Cognitive Sparing in Proton versus Photon Radiotherapy for Pediatric Brain Tumor Is Associated with White Matter Integrity: An Exploratory Study
Cancers 2023cited by 25position: middledoi
Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective
EJC Paediatric Oncology 2023cited by 11position: middledoi
Late-onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly-diagnosed pediatric medulloblastoma
2023cited by 0position: contributordoi
Children’s Oncology Group’s 2023 Blueprint for Research: Rare Tumors
2023cited by 0position: contributordoi
Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group
Neuro-Oncology 2022cited by 35position: lastdoi
Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534).
2022cited by 14position: contributordoi
MEDB-74. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
Neuro-Oncology 2022cited by 0position: middledoi
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)
Journal of Clinical Oncology 2021cited by 231position: middledoi
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
Cancer Cell 2021cited by 174position: middledoi
ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
Cancer Discovery 2021cited by 89position: middledoi
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma
Journal of Clinical Oncology 2021cited by 84position: middledoi
Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials
Clinical Cancer Research 2021cited by 67position: middledoi
Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion
Advanced Science 2021cited by 33position: middledoi
Cognitive Predictors of Social Adjustment in Pediatric Brain Tumor Survivors Treated with Photon versus Proton Radiation Therapy
2021cited by 0position: contributordoi
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group
The Lancet Oncology 2020cited by 232position: middledoi
Germline Elongator mutations in Sonic Hedgehog medulloblastoma
Nature 2020cited by 170position: middledoi
MBRS-20. CSF-DERIVED CIRCULATING TUMOR DNA AS A BIOMARKER FOR DISEASE PROGRESSION AND TUMOR EVOLUTION IN MEDULLOBLASTOMA
Neuro-Oncology 2020cited by 1position: middledoi
MBCL-08. INTEGRATIVE MOLECULAR ANALYSIS OF PATIENT-MATCHED DIAGNOSTIC AND RELAPSED MEDULLOBLASTOMAS
Neuro-Oncology 2020cited by 0position: middledoi
MBCL-21. GERMLINE ELONGATOR MUTATIONS IN SONIC HEDGEHOG MEDULLOBLASTOMA
Neuro-Oncology 2020cited by 0position: middledoi
ETMR-06. DISSECTING THE MOLECULAR AND DEVELOPMENTAL BASIS OF PINEOBLASTOMA THROUGH GENOMICS
Neuro-Oncology 2020cited by 0position: middledoi
Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma
Journal of Clinical Oncology 2019cited by 251position: middledoi
Global Disparities in Wilms Tumor
Journal of Surgical Research 2019cited by 118position: middledoi
Germline <i>GPR161</i> Mutations Predispose to Pediatric Medulloblastoma
Journal of Clinical Oncology 2019cited by 70position: middledoi
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials
Acta Neuropathologica 2019cited by 63position: middledoi
PATH-54. MULTI-DIMENSIONAL MOLECULAR CHARACTERIZATION OF PATIENT-MATCHED MEDULLOBLASTOMA AT DIAGNOSIS AND RELAPSE
Neuro-Oncology 2019cited by 0position: middledoi
PDTM-17. MiR-126, miR-369-5p AND miR-487b DRIVE PEDIATRIC GLIOBLASTOMA INVASION VIA KCNA1
Neuro-Oncology 2019cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 8 papers (2021–2026)Amar Gajjar · Mills Peninsula Health Services8 papers (2015–2020)Giles Robinson · Children's Research Hospital8 papers (2015–2020)Daniel C. Bowers · Massachusetts General Hospital7 papers (2018–2020)Arnold C Paulino · American Society for Radiation Oncology6 papers (2021–2026)Arnold C. Paulino · The University of Texas MD Anderson Cancer Center6 papers (2014–2023)M. Fatih Okcu · Baylor College of Medicine6 papers (2014–2023)David R. Grosshans · The University of Texas MD Anderson Cancer Center6 papers (2014–2023)Stefan M. Pfister · Université du Québec6 papers (2018–2021)Paul A. Northcott · Children's Research Hospital6 papers (2018–2020)Michael J. Fisher · Stanford Medicine5 papers (2015–2020)Rahul Kumar · Galgotias University5 papers (2018–2020)Brent A. Orr · Research Institute of Radiology5 papers (2018–2020)Éric Bouffet · Université Laval5 papers (2018–2020)Tim Hassall · Children’s Health Queensland Hospital and Health Service4 papers (2015–2020)Lisa S. Kahalley · Baylor College of Medicine4 papers (2014–2023)William E. Whitehead · University of North Carolina at Chapel Hill4 papers (2014–2023)Xiao‐Nan Li · Lanzhou University3 papers (2013–2021)David Jones · Mayo Clinic in Florida3 papers (2018–2020)Maximilian Deng · Heidelberg University3 papers (2018–2020)